Metoclopramide poisoning in children L C K LOW AND K M GOEL Royal Hospital for Sick Children, Glasgow SUMMARY 15 children with metoclopramide (MaxoIon) poisoning are reported. One of the 5 children accidentally poisoned developed slight extrapyramidal signs. All 10 children who experienced extrapyramidal side effects while being treated with metoclopramide had received a dose greater than that recommended by the manufacturer of 0 *5 mg/kg per day. Dystonic reactions are likely to occur if the recommended dose is exceeded, but individual susceptibility to metoclopramide and the cumulative effect of repeated doses of the drug may also be important.
Metoclopramide (Maxolon), a chlorbenzamide derivative, is an antiemetic drug which has been available in the UK since 1967. It is regarded as a safe drug with few side effects and has been recommended for habitual vomiting, drug-induced vomiting, and as an adjunct to x-ray examination ofthe upper alimentary tract.' However, alarming extrapyramidal side effects have been reported in children receiving the recommended dose,p3 and in children who have taken the drug in excess. 45 We have looked at a number of children who required admission to this hospital after accidental poisoning by this drug or as a result of its extrapyramidal side effects.
Patients and method
Between January 1967 and December 1978, 15 children were admitted to this hospital with metoclopramide poisoning. Most of the cases occurred during the last 5 years (Figure) . The Accidental poisoning group. Five children were admitted because of accidental poisoning by metoclopramide. The drug had been prescribed for other members of the family in 4 cases and in the remaining child the drug had been prescribed for the patient himself because of gastroenteritis. These 5 children were all under 4 years (range 1 year 5 months to 3 years 6 months) and the dose ingested varied between 50 and 100 mg (that is, 3 3 to 8 3 mg/kg per day). Gastric lavage was carried out within four hours of ingestion in all 5 patients. Motor restlessness and increased muscle tone in the limbs were noticed in one patient and these symptoms settled spontaneously. The other 4 children were symptom-free during their time in hospital.
Therapeutic poisoning group. During the same period, 10 children were admitted because of dystonic reaction caused by metoclopramide. The drug had been prescribed for these patients because of vomiting associated with upper respiratory infection, influenza, or gastroenteritis. Four of these children were also receiving antibiotics at the same time. These patients were older than those in the accidental poisoning group, the average age being 8 years 9 months (range 5 months to 11 years 7 months). In most of them the extrapyramidal side effects had become manifest within 36 hours of starting treatment. In one patient the symptoms began after 6 days oftreatment with metoclopramide. All the patients were conscious at the time of presentation and appeared agitated. Opisthotonos, increased muscle tone in the limbs, and torticollis were the most common abnormal physical signs in these patients at admission. The other symptoms and signs are summarised in Table 2 . In 4 patients these extrapyramidal signs were episodic, each episode generally lasting between 5 and 10 minutes. Apart from restlessness, the patients were symptom-free between these attacks. The dose of metoclopramide taken by these 10 patients varied between 0 9 and 1 9 mg/kg per day. In 2 patients the extrapyramidal manifestations were stopped by giving 1 mg IV benztropine, while the symptoms settled spontaneously within 12 hours in the remaining 8 patients.
Discussion
Extrapyramidal side effects are a rare complication of treatment with metoclopramide. All the patients in the present series were conscious at the time of admission and motor restlessness rather than drowsiness was observed. Opisthotonos and torticollis were the two most common extrapyramidal manifestations in our patients. In 4 of the patients in the therapeutic group the symptoms were episodic as has previously been noted.'4 When the drug was stopped the symptoms settled spontaneously within 12 hours. We found that parenteral administration of benztropine was effective in stopping metoclopramide-induced dystonic reactions. Treatment with barbiturate has been found to be effective also.2-3 All 10 patients in the therapeutic group had received metoclopramide in a dose greater than that currently recommended by the manufacturers, 0 5 mg/kg per day (Table 1) . Although it has been reported3 that children can have these side effects with the dose recommended by the manufacturer, their patients received a dose varying between 0 f56 and 1 * 15 mg/kg per day. In the article by Witzel2 the weights ofthe patients were not given. If one assumes that these were average, the patients received a dose greater than that currently recommended. In other reports extrapyramidal side effects have been observed in children who were overdosed.46
Although it is dijfficult to be certain of the dose taken by the children who were accidentally poisoned by metoclopramide, no child in this series had severe dystonic reactions, despite the possibility of having taken a large quantity of the drug. From our observation and that of others, metoclopramide is sometimes prescribed in the treatment of trivial illness. As dystonic reactions are distressing both to the patients and their parents, greater care should be exercised by doctors when preEcribing this drug for children. The dose should not exceed 0 5 mg/kg per day and prolonged use of the drug is not recommended. Extrapyramidal side effects after metoclopramide are rare and early diagnosis will depend on doctors being alert to the possibility so that unnecessary investigations can be avoided. Such reactions can be effectively stopped by administration of benztropine 1 mg intravenously.
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